Vidal GA - Search Results

1

Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.

Vidal GA, Naresh A, Marrero L, Jones FE. Vidal GA, et al. J Biol Chem. 2005 May 20;280(20):19777-83. doi: 10.1074/jbc.M412457200. Epub 2005 Mar 3. J Biol Chem. 2005. PMID: 15746097 Free article.

2

A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.

Vidal GA, Clark DE, Marrero L, Jones FE. Vidal GA, et al. Oncogene. 2007 Jan 18;26(3):462-6. doi: 10.1038/sj.onc.1209794. Epub 2006 Jul 10. Oncogene. 2007. PMID: 16832345

3

The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone.

Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE. Williams CC, et al. Among authors: vidal ga. J Cell Biol. 2004 Nov 8;167(3):469-78. doi: 10.1083/jcb.200403155. J Cell Biol. 2004. PMID: 15534001 Free PMC article.

4

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells.

Naresh A, Long W, Vidal GA, Wimley WC, Marrero L, Sartor CI, Tovey S, Cooke TG, Bartlett JM, Jones FE. Naresh A, et al. Among authors: vidal ga. Cancer Res. 2006 Jun 15;66(12):6412-20. doi: 10.1158/0008-5472.CAN-05-2368. Cancer Res. 2006. PMID: 16778220 Free article.

5

Impact of Anti-HER2 Treatments Combined With Atezolizumab on the Tumor Immune Microenvironment in Early or Metastatic Breast Cancer: Results From a Phase Ib Study.

Hamilton EP, Kaklamani V, Falkson C, Vidal GA, Ward PJ, Patre M, Chui SY, Rotmensch J, Gupta K, Molinero L, Li Y, Emens LA. Hamilton EP, et al. Among authors: vidal ga. Clin Breast Cancer. 2021 Dec;21(6):539-551. doi: 10.1016/j.clbc.2021.04.011. Epub 2021 May 15. Clin Breast Cancer. 2021. PMID: 34154926 Clinical Trial.

6

Genomic and phylogenic comparisons of the alpha-globin and beta-globin intergenic sequences between zebra fish (Danio rerio) and six closely related Cyprinindae species.

Vidal G, Scheffler B, Michel A, D'Surney SJ. Vidal G, et al. DNA Cell Biol. 2004 May;23(5):325-34. doi: 10.1089/104454904323090958. DNA Cell Biol. 2004. PMID: 15169611

7

Molecular characterization of ESR1 variants in breast cancer.

Heeke AL, Elliott A, Feldman R, O'Connor HF, Pohlmann PR, Lynce F, Swain SM, Nunes MR, Magee D, Oberley MJ, Swenson J, Vidal G, Isaacs C, Schwartzberg L, Korn WM, Tan AR. Heeke AL, et al. Breast Cancer Res Treat. 2022 Nov;196(2):279-289. doi: 10.1007/s10549-022-06740-y. Epub 2022 Sep 20. Breast Cancer Res Treat. 2022. PMID: 36125660

8

Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.

Heeke AL, Xiu J, Elliott A, Korn WM, Lynce F, Pohlmann PR, Isaacs C, Swain SM, Vidal G, Schwartzberg LS, Tan AR. Heeke AL, et al. Breast Cancer Res Treat. 2020 Nov;184(2):265-275. doi: 10.1007/s10549-020-05849-2. Epub 2020 Aug 10. Breast Cancer Res Treat. 2020. PMID: 32776290

9

Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer.

Vontela N, Koduri V, Schwartzberg LS, Vidal GA. Vontela N, et al. Among authors: vidal ga. J Natl Compr Canc Netw. 2017 Mar;15(3):284-287. doi: 10.6004/jnccn.2017.0029. J Natl Compr Canc Netw. 2017. PMID: 28275030

10

Development of a Prognostic Factor Index Among Women With HR⁺/HER2^- Metastatic Breast Cancer in a Community Oncology Setting.

Vidal GA, Carter GC, Gilligan AM, Saverno K, Zhu YE, Price GL, DeLuca A, Smyth EN, Rybowski S, Huang YJ, Schwartzberg LS. Vidal GA, et al. Clin Breast Cancer. 2021 Aug;21(4):317-328.e7. doi: 10.1016/j.clbc.2020.12.012. Epub 2021 Jan 1. Clin Breast Cancer. 2021. PMID: 33678566 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page